Gene Expression Profiling in Multiple Sclerosis Brain

Overview

Journal Neurobiol Dis

Specialty Neurology

Date 2010 Dec 15

PMID 21147224

Citations 16

Authors

Ranjan Dutta

Bruce D Trapp

Affiliations

Soon will be listed here.

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system and the leading cause of non-traumatic neurological disability in young adults in the United States and Europe. The clinical disease course is variable and starts with reversible episodes of neurological disability in the third or fourth decade of life. Microarray-based comparative gene profiling provides a snapshot of genes underlying a particular condition. Several large scale microarray studies have been conducted using brain tissue from MS patients. In this review, we summarize existing data from different gene expression profiling studies and how they relate to understand the pathogenesis of MS.

Citing Articles

Single-nucleus transcriptomic analysis reveals the relationship between gene expression in oligodendrocyte lineage and major depressive disorder.

Xie Y, Chen L, Wang L, Liu T, Zheng Y, Si L J Transl Med. 2024; 22(1):109.

PMID: 38281050 PMC: 10822185. DOI: 10.1186/s12967-023-04727-x.

Identification of potential regulatory long non-coding RNA-associated competing endogenous RNA axes in periplaque regions in multiple sclerosis.

Sabaie H, Rouz S, Kouchakali G, Heydarzadeh S, Asadi M, Sharifi-Bonab M Front Genet. 2022; 13:1011350.

PMID: 36324503 PMC: 9619104. DOI: 10.3389/fgene.2022.1011350.

Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure.

Scalabrino G Biomedicines. 2022; 10(4).

PMID: 35453565 PMC: 9026986. DOI: 10.3390/biomedicines10040815.

Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics.

Kamma E, Lasisi W, Libner C, Ng H, Plemel J J Neuroinflammation. 2022; 19(1):45.

PMID: 35144628 PMC: 8830034. DOI: 10.1186/s12974-022-02408-y.

New Epidermal-Growth-Factor-Related Insights Into the Pathogenesis of Multiple Sclerosis: Is It Also Epistemology?.

Scalabrino G Front Neurol. 2021; 12:754270.

PMID: 34899572 PMC: 8664554. DOI: 10.3389/fneur.2021.754270.

References

Ascherio A, Munger K . Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol. 2007; 61(6):504-13. DOI: 10.1002/ana.21141. View

Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S . Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain. 2000; 123 ( Pt 2):308-17. DOI: 10.1093/brain/123.2.308. View

Gregory S, Schmidt S, Seth P, Oksenberg J, Hart J, Prokop A . Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet. 2007; 39(9):1083-91. DOI: 10.1038/ng2103. View

Eady J, Wortley G, Wormstone Y, Hughes J, Astley S, Foxall R . Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics. 2005; 22(3):402-11. DOI: 10.1152/physiolgenomics.00080.2005. View

Rosati G . The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001; 22(2):117-39. DOI: 10.1007/s100720170011. View

Ramanathan M, Weinstock-Guttman B, Nguyen L, Badgett D, Miller C, Patrick K . In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J Neuroimmunol. 2001; 116(2):213-9. DOI: 10.1016/s0165-5728(01)00308-3. View

GANTER P, Prince C, Esiri M . Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol. 2000; 25(6):459-67. DOI: 10.1046/j.1365-2990.1999.00205.x. View

Hardingham G, Fukunaga Y, Bading H . Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 2002; 5(5):405-14. DOI: 10.1038/nn835. View

Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, Rajewsky K . Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A. 2004; 101(8):2428-33. PMC: 356967. DOI: 10.1073/pnas.0308689100. View

10.

Oksenberg J, Baranzini S, Sawcer S, Hauser S . The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet. 2008; 9(7):516-26. DOI: 10.1038/nrg2395. View

11.

Huseby E, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman J . A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med. 2001; 194(5):669-76. PMC: 2195947. DOI: 10.1084/jem.194.5.669. View

12.

Ferguson B, Matyszak M, Esiri M, Perry V . Axonal damage in acute multiple sclerosis lesions. Brain. 1997; 120 ( Pt 3):393-9. DOI: 10.1093/brain/120.3.393. View

13.

Weiner H . The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?. Ann Neurol. 2009; 65(3):239-48. DOI: 10.1002/ana.21640. View

14.

Peterson J, Bo L, Mork S, Chang A, Trapp B . Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 2001; 50(3):389-400. DOI: 10.1002/ana.1123. View

15.

Hauser S, Oksenberg J . The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron. 2006; 52(1):61-76. DOI: 10.1016/j.neuron.2006.09.011. View

16.

Bo L, Vedeler C, Nyland H, Trapp B, Mork S . Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler. 2003; 9(4):323-31. DOI: 10.1191/1352458503ms917oa. View

17.

Lipton S, Rosenberg P . Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994; 330(9):613-22. DOI: 10.1056/NEJM199403033300907. View

18.

Waxman S . Sodium channel blockers and axonal protection in neuroinflammatory disease. Brain. 2004; 128(Pt 1):5-6. DOI: 10.1093/brain/awh353. View

19.

Bomprezzi R, Ringner M, Kim S, Bittner M, Khan J, Chen Y . Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet. 2003; 12(17):2191-9. DOI: 10.1093/hmg/ddg221. View

20.

Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H . Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002; 8(5):500-8. DOI: 10.1038/nm0502-500. View